Skip to content
HomeThe Road to a Vaccine

The Road to a Vaccine: How 3 brilliant women are changing the game when it comes to COVID-19

In Season 2 of The Road to a Vaccine, host Lisa Ling interviews scientists, global health leaders and other experts on the COVID-19 front lines to reveal the latest medical advances and collaborations to create a coronavirus vaccine—and hopefully a return to a world without the pandemic.

In Episode 11 of The Road to a Vaccine, Lisa Ling speaks to Dr. Uché Blackstock about the racial inequities the pandemic has exposed, Dr. Alison Schwartz about battling a COVID-19 spike in Wisconsin and 14-year-old Anika Chebrolu about her prize-winning potential coronavirus therapy.

Note: This program originally aired on Nov. 10, 2020.
RTAV: Season 2, Episode 11
Host Lisa Ling (left) speaking with Anika Chebrolu (right) about a potential COVID-19 treatment

Lisa Ling

Ling is the Executive Producer and host of This Is Life on CNN. She has also been a field correspondent for The Oprah Winfrey Show and a contributor to ABC News’ Nightline.

Uché Blackstock, M.D.

Dr. Blackstock is a thought leader and sought-after speaker on racialized health inequities and racism in health care. She is the Founder and CEO of Advancing Health Equity, which partners with healthcare and related organizations to address the critical factors contributing to health inequity. In 2019, Dr. Blackstock was recognized by Forbes magazine as of one of 10 Diversity and Inclusion Trailblazers You Need to Get Familiar With.
Anika Chebrolu

Anika Chebrolu

Chebrolu was named “America’s Top Young Scientist” after winning 3M’s 2020 Young Scientist Challenge for her discovery of a potential anti-viral therapy for SARS-CoV-2. She is passionate about STEM advocacy, runs her own non-profit for underserved students, plays the guitar and has practiced Bharatanatyam (a classical Indian Dance) since she was six years old.

Alison Schwartz, D.O.

Dr. Schwartz is an Associate Medical Director of Infectious Disease for SSM Health’s Wisconsin Region. She treats patients in Madison and Janesville, Wisconsin.

Have questions about participating in a COVID-19 vaccine clinical trial? A doctor overseeing a study helps answer them

Njira Lugogo, M.D., is a pulmonologist at the University of Michigan who is leading a clinical study of an investigational COVID-19 vaccine candidate. She helps answer common questions people may have about the process, from what people over 60 need to know to how participants are being kept safe during the pandemic.
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.